FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $149,000 | +122.4% | 3,958 | 0.0% | 0.00% | – |
| Q4 2020 | $67,000 | +103.0% | 3,958 | -43.5% | 0.00% | – |
| Q3 2020 | $33,000 | -23.3% | 7,002 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +168.8% | 7,002 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -50.0% | 7,002 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | +18.5% | 7,002 | 0.0% | 0.00% | – |
| Q3 2019 | $27,000 | -35.7% | 7,002 | 0.0% | 0.00% | – |
| Q2 2019 | $42,000 | -55.3% | 7,002 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $94,000 | +44.6% | 7,002 | 0.0% | 0.00% | – |
| Q4 2018 | $65,000 | -33.0% | 7,002 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $97,000 | +148.7% | 7,002 | +180.6% | 0.00% | – |
| Q2 2018 | $39,000 | -9.3% | 2,495 | 0.0% | 0.00% | – |
| Q1 2018 | $43,000 | -21.8% | 2,495 | 0.0% | 0.00% | – |
| Q4 2017 | $55,000 | – | 2,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |